(Q37830198)

24 August 2017

1 reference

title

Type 1 diabetes: etiology, immunology, and therapeutic strategies (English)

1 reference

24 August 2017

0 references

0 references

Matthias G von Herrath

series ordinal

3

object named as

Matthias G von Herrath

1 reference

24 August 2017

2

Ken T Coppieters

1 reference

24 August 2017

Tom L van Belle

1

1 reference

24 August 2017

language of work or name

1 reference

1 January 2011

1 reference

24 August 2017

published in

Physiological Reviews

1 reference

24 August 2017

volume

91

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

79-118

1 reference

Natural history of type 1 diabetes

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Beta-cell mass and type 1 diabetes: going, going, gone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Extreme genetic risk for type 1A diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Projection of an immunological self shadow within the thymus by the aire protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

No evidence for serological autoimmunity to islet cell heat shock proteins in insulin dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Defective regulatory and effector T cell functions in patients with FOXP3 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The effect of infections on susceptibility to autoimmune and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Induction of the chemokine interferon-gamma-inducible protein-10 in human pancreatic islets during enterovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

CTLA4Ig: bridging the basic immunology with clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Linear loss of insulin secretory capacity during the last six months preceding IDDM. No effect of antiedematous therapy with ketotifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Role of PTPN22 in type 1 diabetes and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Regulation of pancreatic beta-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Moving towards efficient therapies in type 1 diabetes: to combine or not to combine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autoimmunity is a type I interferon-deficiency syndrome corrected by ingested type I IFN via the GALT system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Ingested (oral) IFN-alpha represses TNF-alpha mRNA in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Human regulatory T cells: role in autoimmune disease and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Congenital rubella and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autoimmune manifestations in primary immune deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The replication of beta cells in normal physiology, in disease and for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

CD3-specific antibodies: a portal to the treatment of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Coxsackie B virus infection and onset of childhood diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Genetics of type 1A diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Histopathology of type 1 diabetes: old paradigms and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Diabetes mellitus: induction in mice by encephalomyocarditis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Liraglutide: a review of its use in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Efficient differentiation of human embryonic stem cells to definitive endoderm

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

An increased level of antibodies to beta-lactoglobulin is a risk determinant for early-onset type 1 (insulin-dependent) diabetes mellitus independent of islet cell antibodies and early introduction of cow's milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Lack of causal association between Coxsackie B4 virus infection and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Effects of insulin in relatives of patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Type I diabetes mellitus. A chronic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Effect of bacille Calmette-Guérin vaccination on C-peptide secretion in children newly diagnosed with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Thymus-specific deletion of insulin induces autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Viral trigger for type 1 diabetes: pros and cons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Congenital rubella: citation virus or viral cause of type 1 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Viral antibodies in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Interleukin 2 and soluble interleukin 2-receptor secretion defect in vitro in newly diagnosed type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Common genetic variation and human traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autoimmune diabetes and resistance to xenograft transplantation tolerance in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A case of fulminant type 1 diabetes associated with significant elevation of mumps titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Trends in the incidence of childhood-onset diabetes in Europe 1989-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Isolation, expansion, and characterization of human natural and adaptive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Beneficial effects of K-ATP channel openers in diabetes: an update on mechanisms and clinical experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Exendin-4 modulates diabetes onset in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autologous umbilical cord blood transfusion in very young children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Beta cell MHC class I is a late requirement for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Current advances and travails in islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Cow's milk and type 1 diabetes: the real debate is about mucosal immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

How robust is the evidence for viruses in the induction of type 1 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Childhood vaccination and type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Screening for insulitis in adult autoantibody-positive organ donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Cyclosporin A treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus. London Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Pioglitazone might prevent the progression of slowly progressive type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The Diabetes Control and Complications Trial: the gift that keeps giving

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Immune cell crosstalk in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Aire regulates negative selection of organ-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes--the PRODIA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Therapy with GAD in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

beta-cell function in children with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Human lymphocyte antigen DR types in relation to early clinical manifestations in diabetic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A type 1 diabetes-related protein from wheat (Triticum aestivum). cDNA clone of a wheat storage globulin, Glb1, linked to islet damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Genetic susceptibility to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Tolerance, not immunity, crucially depends on IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A new role for an old player: do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Two-dose daclizumab, tacrolimus, mycophenolate mofetil, and steroid-free regimen in de novo cardiac transplant recipients: early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Seasonality of birth in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

beta-Cell death during progression to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Reduced risk of IDDM among breast-fed children. The Colorado IDDM Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Discovering the role of the major histocompatibility complex in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Letter: Diabetes, HL-A antigens, and congenital rubella.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Intracellular pattern recognition receptors in the host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Role of autoantibodies in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to beta-cell autoimmunity and to remaining beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Partial remission phase of diabetes in children younger than age 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

HL-A antigens and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Recovery from diabetes in mice by beta cell regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The HLA class I A locus affects susceptibility to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Timing of Initial Cereal Exposure in Infancy and Risk of Islet Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

ASSOCIATION OF CYTOMEGALOVIRUS INFECTION WITH AUTOIMMUNE TYPE 1 DIABETES

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Cow's milk-free diet does not prevent diabetes in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Islet allograft survival induced by costimulation blockade in NOD mice is controlled by allelic variants of Idd3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

How to interpret a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The anti-interleukin-1 in type 1 diabetes action trial--background and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Intramuscular injection of islet neogenesis-associated protein peptide stimulates pancreatic islet neogenesis in healthy dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Expansion of human regulatory T-cells from patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A cis-Acting Regulatory Variant in the IL2RA Locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Islet transplantation as a treatment for diabetes - a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Role of enteroviruses in the pathogenesis of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberculosis with type-1 but not type-2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Five-year follow-up after clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Imaging the Beta-cell mass: why and how

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Humoral immune responses of type 1 diabetes patients to Mycobacterium avium subsp. paratuberculosis lend support to the infectious trigger hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

International trial of the Edmonton protocol for islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A comprehensive review of interventions in the NOD mouse and implications for translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Invasion of the killer B's in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Histocompatibility (HL-A) Antigens, Lymphocytotoxic Antibodies and Tissue Antibodies in Patients with Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Beta-cell replacement for type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Homeostasis of memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Interleukin-21 is required for the development of type 1 diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Toll-like receptor 2 controls expansion and function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Real-time bioluminescence imaging of macroencapsulated fibroblasts reveals allograft protection in rhesus monkeys (Macaca mulatta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

A molecular perspective of CTLA-4 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children--no evidence of increased antibody frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Prevention of diabetes: effect of mycophenolate mofetil and anti-CD25 on onset of diabetes in the DRBB rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Extended DR3-D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

AIRE and APECED: molecular insights into an autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Stem cell transplantation for type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

How can we improve the translational landscape for a faster cure of type 1 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Remodeling rodent models to mimic human type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Type 1 diabetes as a relapsing-remitting disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Microorganisms and autoimmunity: making the barren field fertile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Type 1 diabetes genes and pathways shared by humans and NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Analysis of islet inflammation in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Identification of substrates of human protein-tyrosine phosphatase PTPN22

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

In vitro characterization of five humanized OKT3 effector function variant antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Isolation of a virus from the pancreas of a child with diabetic ketoacidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Coxsackie virus B4 produces transient diabetes in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Human induced pluripotent stem cells free of vector and transgene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Rapamycin impairs in vivo proliferation of islet beta-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

In vivo reprogramming of adult pancreatic exocrine cells to beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Early Infant Feeding and Risk of Developing Type 1 Diabetes–Associated Autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

High prevalence of coeliac disease in siblings of children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

Identification of a -Cell-Specific HLA Class I Restricted Epitope in Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00003.2010

T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors.

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1096/FJ.02-1139FJE

Identifiers

DOI

10.1152/PHYSREV.00003.2010

1 reference

24 August 2017

1 reference